T Ashikaga
Overview
Explore the profile of T Ashikaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reardon J, Berkett L, Garcia M, Gotlieb A, Ashikaga T, Badger G
Plant Dis
. 2019 Feb;
89(3):228-236.
PMID: 30795343
Most fungicide sprays applied to apple orchards in the New England states are targeted at the management of apple scab. Researchers have developed action thresholds that aid in decision-making on...
2.
Ades S, Halyard M, Wilson K, Ashikaga T, Heimann R, Kumar S, et al.
Support Care Cancer
. 2016 Dec;
25(5):1503-1510.
PMID: 28032216
Purpose: Despite a lower risk of nausea and vomiting in patients receiving radiotherapy to the upper abdomen (UA-RINV) with prophylactic 5-HT3 antagonist therapy, patients can still experience UA-RINV. The aim...
3.
Moukharskaya J, Abrams D, Ashikaga T, Khan F, Schwartz J, Wilson K, et al.
Support Care Cancer
. 2016 Feb;
24(7):3085-93.
PMID: 26894485
Purpose: Bone pain is a common side effect of pegfilgrastim and can interfere with quality of life and treatment adherence. This study investigated the impact of antihistamine prophylaxis on pegfilgrastim-induced...
4.
Ades S, Kumar S, Alam M, Goodwin A, Weckstein D, Dugan M, et al.
J Thromb Haemost
. 2015 Mar;
13(6):998-1003.
PMID: 25809746
Background: Patients with metastatic colon cancer (mCRC) are at increased risk of venous thromboembolism (VTE). Limited preclinical data suggest that the oncogene (KRAS) mutational status of the tumor represents a...
5.
Yarger J, James T, Ashikaga T, Hayanga A, Takyi V, Lum Y, et al.
Surgery
. 2013 Jul;
154(1):38-45.
PMID: 23809484
Background: Surveys are important research tools that permit the accumulation of information from large samples that would otherwise be impractical to collect. Resident surveys have been used frequently to monitor...
6.
Aeby P, Ashikaga T, Bessou-Touya S, Schepky A, Gerberick F, Kern P, et al.
Toxicol In Vitro
. 2010 Jul;
24(6):1465-73.
PMID: 20624454
The sensitizing potential of chemicals is usually identified and characterized using one of the available animal test methods, such as the mouse local lymph node assay. Due to the increasing...
7.
Sakaguchi H, Ashikaga T, Miyazawa M, Yoshida Y, Ito Y, Yoneyama K, et al.
Toxicol In Vitro
. 2005 Dec;
20(5):774-84.
PMID: 16337770
Recent regulatory changes have placed a major emphasis on in vitro safety testing and alternative models. In regard to skin sensitization tests, dendritic cells (DCs) derived from human peripheral blood...
8.
Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, et al.
Toxicol In Vitro
. 2005 Nov;
20(5):767-73.
PMID: 16311011
The aim of this study is to optimize the experimental conditions for an in vitro skin sensitization test using the human cell lines THP-1 and U-937. As regards pre-culturing time,...
9.
Kucharekova M, Hornix M, Ashikaga T, Tkint S, de Jongh G, Schalkwijk J, et al.
Arch Dermatol Res
. 2003 Apr;
295(1):29-32.
PMID: 12709818
Background: New therapeutic approaches have to be considered in the treatment of irritant contact dermatitis (ICD). Recently, phosphodiesterase 4 (PDE-4) inhibitors have been introduced as nonsteroidal, antiinflammatory agents. These agents...
10.
Ashikaga T, Hoya M, Itagaki H, Katsumura Y, Aiba S
Toxicol In Vitro
. 2002 Nov;
16(6):711-6.
PMID: 12423654
The aim of this study was to explore the usefulness of a human monocyte cell line in the development of in vitro models for predictive testing of contact sensitizers. Several...